Guillain-Barre syndrome

(redirected from Gbs)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for Guillain-Barre syndrome

a form of peripheral polyneuritis characterized by pain and weakness and sometimes paralysis of the limbs

References in periodicals archive ?
GBS is a private company headquartered in the United Arab Emirates.
He said there are more than 60 companies with GBS operations in Penang employing over 12,000 workers in high-value jobs.
Floyd brings more than 30 years of comprehensive sales experience to GBS, much of which came from his time in the insurance, mortgage, and executive commercial transportation industries.
According to the report, the American Academy of Pediatrics supports the American College of Obstetricians and Gynecologists-recommended maternal policies and procedures for prevention of perinatal GBS disease.
Reportedly, in 2018, the US Food and Drug Administration had granted Orphan Drug Designation to imlifidase for the treatment of GBS.
The researchers also looked at GBS serotype data in 1,743 patients from seven different centers.
As part of the response, in February 2016 PRDH and CDC with collaboration from the University of Puerto Rico established the Enhanced Guillain-Barre Syndrome Surveillance System (EGBSSS) to: 1) prospectively identify cases of GBS and other neurologic disorders, 2) provide healthcare providers with arbovirus diagnostic testing results (i.e., infection with ZIKV, DENV, and CHIKV), and 3) compare 2016 GBS epidemiologic trends with prior years in Puerto Rico and to other countries affected by ZIKV.
Various selective media are used to isolate GBS. These include CHROMagar StrepB (CHROMagar, France) ChromID Strepto B agar (bioMerieux, France) and the Granada medium (bioMerieux, France).
Consequently, AMAN, a rare subtype of GBS, was more likely to be considered and plasma (PE) or the second use of IVIG was recommended, but family members refused to exchange by plasma.
For the prediction of high-risk patients, area under the curve (AUC) was obtained for GBS (0.912), PRS (0.968), CRS (0.991), and CSMCPI (0.918).
GBS is a rare but serious autoimmune syndrome that attacks the peripheral nerves, causing a progressive paralysis.
GBS is the UK's most common cause of life-threatening infection in newborn babies, with 500 affected in the UK in 2015.
Mr Hunt said: "By providing all pregnant women with an information leaflet on GBS for the first time, we can help to raise awareness and save the lives of babies."